Characterizing the specificity of activated factor XIII for glutamine-containing substrate peptides

被引:27
作者
Cleary, David B. [1 ]
Maurer, Muriel C. [1 ]
机构
[1] Univ Louisville, Dept Chem, Louisville, KY 40292 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2006年 / 1764卷 / 07期
关键词
factor XIII; transglutaminase; coagulation; deamidation; NMR; kinetic;
D O I
10.1016/j.bbapap.2006.05.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activated Factor XIII (FXIIIa) is a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine crosslinks in the fibrin network. To better understand the source of FXIIIa substrate specificity, Q-containing substrates based on beta-casein, K9-peptide, and alpha(2)-antiplasmin were characterized. alpha(2)AP (1-15, Q2, Q4) and alpha(2)AP (1 -15, Q2, Q4N, K12R) are highly promising peptide models since they exhibited k(cat)/K-m values comparable to intact beta-casein. In the absence of a lysine-like donor, FXIIIa could promote deamidation of a reactive Q to an E and solution NMR served as an effective strategy for monitoring this reaction. A tendency toward deamidation allowed greater investigations of the alpha(2)-antiplasmin based peptides. FXIIIa preferentially selects the Q2 residue for carrying out crosslinking processes. The E3 and Q4 provide supporting roles in binding. When a crosslinking reaction occurs at Q2, the Q4 position is sterically blocked from reactivity. By contrast, deamidation of Q2 to E2 allows, for the first time, observation of reactivity at Q4. The K12 position provides an additional favorable site of interaction with the FXIIIa surface. The sensitivity of alpha(2)AP (1-15, Q2, Q4) to amino acid changes at Q2, Q4, and K12 suggests the importance of individual FXIIIa subsites that are controlled by chemical environment and sterics. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1207 / 1217
页数:11
相关论文
共 41 条
[1]   PLATELET FACTOR-XIII IS ACTIVATED BY CALPAIN [J].
ANDO, Y ;
IMAMURA, S ;
YAMAGATA, Y ;
KITAHARA, A ;
SAJI, H ;
MURACHI, T ;
KANNAGI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 144 (01) :484-490
[2]   Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms [J].
Ariëns, RAS ;
Lai, TS ;
Weisel, JW ;
Greenberg, CS ;
Grant, PJ .
BLOOD, 2002, 100 (03) :743-754
[3]  
BARRY ELR, 1989, J BIOL CHEM, V264, P4179
[4]   EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF HUMAN FACTOR-XIII IN SACCHAROMYCES-CEREVISIAE [J].
BISHOP, PD ;
TELLER, DC ;
SMITH, RA ;
LASSER, GW ;
GILBERT, T ;
SEALE, RL .
BIOCHEMISTRY, 1990, 29 (07) :1861-1869
[5]   THE 2-DIMENSIONAL TRANSFERRED NUCLEAR OVERHAUSER EFFECT - THEORY AND PRACTICE [J].
CAMPBELL, AP ;
SYKES, BD .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1993, 22 :99-122
[6]   LAMBDA-LAMBDA CROSS-LINKING SITES IN HUMAN AND BOVINE FIBRIN [J].
CHEN, R ;
DOOLITTLE, RF .
BIOCHEMISTRY, 1971, 10 (24) :4486-+
[7]   Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface [J].
Cleary, DB ;
Trumbo, TA ;
Maurer, MC .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 403 (02) :179-188
[8]   CALCIUM-DEPENDENT UNMASKING OF ACTIVE-CENTER CYSTEINE DURING ACTIVATION OF FIBRIN STABILIZING FACTOR [J].
CURTIS, CG ;
BROWN, KL ;
CREDO, RB ;
DOMANIK, RA ;
GRAY, A ;
STENBERG, P ;
LORAND, L .
BIOCHEMISTRY, 1974, 13 (18) :3774-3780
[9]  
FICKENSCHER K, 1991, THROMB HAEMOSTASIS, V65, P535
[10]   Gliadin T cell epitope selection by tissue transglutaminase in Celiac disease -: Role of enzyme specificity and pH influence on the transamidation versus deamidation reactions [J].
Fleckenstein, B ;
Molberg, Y ;
Qiao, SW ;
Schmid, DG ;
von der Müllbe, F ;
Elgstoen, K ;
Jung, G ;
Sollid, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :34109-34116